21306-56-9CC[N+](CC)(CC)CC(=O)Nc1c(C)cccc1CPYEBKOFMWAMBFV-UHFFFAOYSA-OQX-314 is a monocarboxylic acid amide. It has a role as a local anaesthetic.
Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
Warning
H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]
P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 38 reports by companies from 1 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Drugs that block nerve conduction when applied locally to nerve tissue in appropriate concentrations. They act on any part of the nervous system and on every type of nerve fiber. In contact with a nerve trunk, these anesthetics can cause both sensory and motor paralysis in the innervated area. Their action is completely reversible. (From Gilman AG, et. al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed) Nearly all local anesthetics act by reducing the tendency of voltage-dependent sodium channels to activate.
UsesBlocker of voltage-activated sodium channels
UsesQX-314 bromide is a derivative of Lidocaine. It is a local anesthetic.
No reaction records under the current filter.
Loading…
21306-56-9DTXSID10943813CHEMBL1180496、CHEMBL128028CHEBI:46937